Hypophysitis Secondary to Cytotoxic T-Lymphocyte–Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series

Hypophysitis that develops in cancer patients treated with monoclonal antibodies blocking cytotoxic T-lymphocyte–associated protein 4 (CTLA-4; an inhibitory molecule classically expressed on T cells) is now reported at an incidence of approximately 10%. Its pathogenesis is unknown, in part because n...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Pathol
Asıl Yazarlar: Caturegli, Patrizio, Di Dalmazi, Giulia, Lombardi, Martina, Grosso, Federica, Larman, H. Benjamin, Larman, Tatianna, Taverna, Giacomo, Cosottini, Mirco, Lupi, Isabella
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Investigative Pathology 2016
Konular:
Regular Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5225294/
https://ncbi.nlm.nih.gov/pubmed/27750046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2016.08.020
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller